TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive Oncologist Urge FDA to Allow Cancer Patients Access to Silicone Implants, But Continue Study March 6, 1992
